Found: 13
Select item for more details and to access through your institution.
Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/pharmaceutics14091784
- By:
- Publication type:
- Article
Kinase Inhibition in Relapsed/Refractory Leukemia and Lymphoma Settings: Recent Prospects into Clinical Investigations.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 10, p. 1604, doi. 10.3390/pharmaceutics13101604
- By:
- Publication type:
- Article
Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8212, doi. 10.3390/ijms23158212
- By:
- Publication type:
- Article
Role of miRNAs in Human T Cell Leukemia Virus Type 1 Induced T Cell Leukemia: A Literature Review and Bioinformatics Approach.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 10, p. 5486, doi. 10.3390/ijms23105486
- By:
- Publication type:
- Article
Solid Tumors and Kinase Inhibition: Management and Therapy Efficacy Evolution.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 7, p. 3830, doi. 10.3390/ijms23073830
- By:
- Publication type:
- Article
Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.
- Published in:
- In Vivo, 2024, v. 38, n. 4, p. 2016, doi. 10.21873/invivo.13659
- By:
- Publication type:
- Article
Nested-PCR vs. RT-qPCR: A Sensitivity Comparison in the Detection of Genetic Alterations in Patients with Acute Leukemias.
- Published in:
- DNA (2673-8856), 2024, v. 4, n. 3, p. 285, doi. 10.3390/dna4030019
- By:
- Publication type:
- Article
PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5510, doi. 10.3390/cancers15235510
- By:
- Publication type:
- Article
Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia.
- Published in:
- Biomedicines, 2023, v. 11, n. 4, p. 1098, doi. 10.3390/biomedicines11041098
- By:
- Publication type:
- Article
Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 5, p. 592, doi. 10.21873/cdp.10368
- By:
- Publication type:
- Article
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 1, p. 9, doi. 10.21873/cdp.10279
- By:
- Publication type:
- Article
Leukemic Stem Cell: A Mini-Review on Clinical Perspectives.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.931050
- By:
- Publication type:
- Article
Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.
- Published in:
- Genes, 2024, v. 15, n. 2, p. 151, doi. 10.3390/genes15020151
- By:
- Publication type:
- Article